Salt and crystal form of egfr inhibitor, and composition and use thereof
US-2024352053-A1 · Oct 24, 2024 · US
Tartaric acid
Tartaric acid · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C59/255 |
| Official title | Tartaric acid |
| Display label | Tartaric acid |
| Total patents | 169 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 16 |
| 2016 | 18 |
| 2017 | 10 |
| 2018 | 8 |
| 2019 | 11 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 15 |
| 2023 | 23 |
| 2024 | 19 |
| 2025 | 21 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND USES THEREFORE
US-2024101564-A1 · Mar 28, 2024 · US
Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine
US-10487053-B2 · Nov 26, 2019 · US
TRPV1 antagonists including dihydroxy substituent and uses thereof
US-10450308-B2 · Oct 22, 2019 · US
Toll like receptor modulator compounds
US-2019282576-A1 · Sep 19, 2019 · US
Substituted guanidine derivatives
US-2019152953-A1 · May 23, 2019 · US
Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
US-2019030015-A1 · Jan 31, 2019 · US
Salts of morpholine derivative, crystal forms thereof, processes for producing the same, pharmaceutical compositions including the same, and use thereof
US-2019016718-A1 · Jan 17, 2019 · US
Cocrystalline DHEA formulations
US-10130713-B2 · Nov 20, 2018 · US
Forms and compositions of biaryl inhibitors of bruton's tyrosine kinase
US-2018282310-A1 · Oct 4, 2018 · US
Polymorphic compounds and uses thereof
US-2018265474-A1 · Sep 20, 2018 · US
Levalbuterol salt
US-2018222845-A1 · Aug 9, 2018 · US
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US-10028944-B2 · Jul 24, 2018 · US
Process for preparation of cysteamine bitartrate
US-2018193292-A1 · Jul 12, 2018 · US
Aryl naphthyl methanone oxime(s) and process for preparation thereof
US-9994515-B2 · Jun 12, 2018 · US
Process or preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds
US-9862719-B2 · Jan 9, 2018 · US
L-tartrate salt of pridopidine
US-9796673-B2 · Oct 24, 2017 · US
Toll like receptor modulator compounds
US-2017281627-A1 · Oct 5, 2017 · US
Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
US-2017209424-A1 · Jul 27, 2017 · US
Trpv1 antagonists including dihydroxy substituent and uses thereof
US-2017183337-A1 · Jun 29, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C59/255?
- CPC C07C59/255 is the Cooperative Patent Classification code for “Tartaric acid.”
- How many patents are filed under CPC C07C59/255 (Tartaric acid)?
- Our database includes 169 publications tagged with this CPC code.
- Is patent activity under CPC C07C59/255 growing?
- Publication counts under this code: 19 in 2024 vs 21 in 2025 (latest complete years).